SYNTHESIS, STRUCTURAL ELUCIDATION AND ANTIMICROBIAL EVALUATION OF 2-{4-(T-AMINO)-2-(BUT-2-YN-1-YL)}-1, 3 BENZOTHIAZOLE DERIVATIVES
Abstract
Objective: A new series of 2-{4-(t-amino)-2-(but-2-yn-1-yl)}-1,3-benzothiazole derivatives, 2-[4-(pyrrolidin-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ2), 2-[4-(2-methylpiperidin-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ3), 2-[4-(piperidin-1-yl) but-2-yn-1-yl]-1,3-benzothiazole (BZ4), 2-[4-(azepan-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ5), 2-[4-(4-methylpiperazin-1-yl) but-2-yn-1-yl]-1,3-benzothiazole (BZ6), 2-[4-(2, 6-dimethylpiperidin-1-yl) but-2-yn-1-yl]-1, 3-benzothiazole (BZ7) were synthesized and screened in vitro as potential antimicrobial agents.
Methods: In-vitro antimicrobial activity evaluation was done, by agar diffusion method and broth dilution test against Staphylococcus aureus ATCC 6538p, Candida albicans ATCC 10231, Pseudomonas aeruginosa ATCC 9027, Escherichia coli ATCC 8739, and Bacillus subtilis ATCC 6633. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) were determined. The results of antimicrobial testing were compared to two positive control drugs ciprofloxacin (5 µg/ml) and fluconazole (500µg/ml).
Results: Compound 2-[4-(azepan-1-yl) but-2-yn-1-yl]-1,3-benzothiazole (BZ5) showed the highest antibacterial activity against S. aureus with MIC value of 15.62 µg/ml while; Compound 2-[4-(2,6-dimethylpiperidin-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ7) exhibited the highest antibacterial activity against P. aeruginosa with MIC value of 31.25 µg/ml. Compounds 2-[4-(pyrrolidin-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ2) and 2-[4-(azepan-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ5) showed the highest antifungal activity against C. albicans with MIC value of 15.62 µg/ml (for both).
Conclusion: The results obtained showed variation in the antibacterial and antifungal activity based on the structure of the cyclic amines in these amino acetylenic benzothiazole derivatives.
Keywords: Benzothiazole, Aminoacetylenic, Antibacterial, Antifungal, Mannich reaction
Downloads
References
Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med 2014;371:1619-28.
Andrews KT, Fisher G, Skinner-Adams TS. Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist 2014;4:95-111.
McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V. Salmonella takes control: effector-driven manipulation of the host. Curr Opin Microbiol 2009;12:117-24.
Dormond L, Jaton K, de Vallière S, Genton B, Greub G. Malaria real-time PCR: correlation with clinical presentation. New Microbes New Infect 2015;5:10-2.
Hai-long Z, Shimin C, Yalan L. Some Chinese folk prescriptions for wind-cold type common cold. Afr J Tradit Complementary Altern Med 2015;5:135-7.
Sun Q, Liu L, Wu L, Li W, Liu Q, Zhang J, et al. Web resources for microbial data. Genomics Proteomics Bioinf 2015;13:69-72.
Ortayli N, Ringheim K, Collins L, Sladden T. Sexually transmitted infections: progress and challenges since the 1994 international conference on population and development (ICPD). Contraception 2014;90 Suppl 6:S22-S31.
Gilani SJ, Nagarajan K, Dixit SP, Taleuzzaman M, Khan SA. Benzothiazole incorporated thiazolidin-4-ones and azetidin-2-ones derivatives: Synthesis and in vitro antimicrobial evaluation. Arab J Chem 2012:4-12. doi:10.1016/ j.arabjc. 2012.04.004. [Article in Press]
Tomi IHR, Tomma JH, Al-Daraji AHR, Al-Dujaili AH. Synthesis, characterization and comparative study the microbial activity of some heterocyclic compounds containing oxazole and benzothiazole moieties. J Saudi Chem Soc 2015;19:392–8.
Chaudhary P, Sharma PK, Sharma A, Varshney J. Recent advances in pharmacological activity of benzothiazole derivatives. Int J Curr Pharm Res 2010;2:5-11.
Ali R, Siddiqui N. Biological aspects of emerging benzothiazoles: a short review. J Chem 2013. doi.org/10.1155/2013/345198. [Article in Press]
Keri RS, Patil MR, Patil SA, Budagumpi S. A comprehensive review in current developments of benzothiazole based molecules in medicinal chemistry. Eur J Med Chem 2015;89:207-51.
Tortora G, Funke B, Case C. Microbiology an introduction. 11th ed. U. S. A: Pearson education; 2013.
Muhi-eldeen Z. Essentials of medicinal chemistry update. 2nd ed. Jordan: Addustour for Printing; 2008.
Kuchta T, Léka C, Farkas P, Bujdáková H, Belajová E, Russell NJ. Inhibition of sterol 4-demethylation in Candida albicans by 6-amino-2-n-pentylthiobenzothiazole, a novel mechanism of action for an antifungal agent. Antimicrob Agents Chemother 1995;39:1538-41.
Georgopapadakou N, Bertasso A. Effects of squalene epoxidase inhibitor on candida albicans. Antimicrob Agents Chemother 1992;36:1779-81.
Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 2005;28:1805-8.